AU2002216033A1 - Use of pyrazolo(4,3-d)pyrimidines - Google Patents
Use of pyrazolo(4,3-d)pyrimidinesInfo
- Publication number
- AU2002216033A1 AU2002216033A1 AU2002216033A AU1603302A AU2002216033A1 AU 2002216033 A1 AU2002216033 A1 AU 2002216033A1 AU 2002216033 A AU2002216033 A AU 2002216033A AU 1603302 A AU1603302 A AU 1603302A AU 2002216033 A1 AU2002216033 A1 AU 2002216033A1
- Authority
- AU
- Australia
- Prior art keywords
- pyrazolo
- pyrimidines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10060388A DE10060388A1 (en) | 2000-12-05 | 2000-12-05 | Use of pyrazolo [4,3-d] pyrimidines |
DE10060388 | 2000-12-05 | ||
PCT/EP2001/013036 WO2002045716A1 (en) | 2000-12-05 | 2001-11-09 | Use of pyrazolo[4,3-d]pyrimidines |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002216033A1 true AU2002216033A1 (en) | 2002-06-18 |
Family
ID=7665844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002216033A Abandoned AU2002216033A1 (en) | 2000-12-05 | 2001-11-09 | Use of pyrazolo(4,3-d)pyrimidines |
Country Status (17)
Country | Link |
---|---|
US (1) | US20040023991A1 (en) |
EP (1) | EP1339410A1 (en) |
JP (1) | JP2004523493A (en) |
KR (1) | KR20030055338A (en) |
CN (1) | CN1479619A (en) |
AU (1) | AU2002216033A1 (en) |
BR (1) | BR0115911A (en) |
CA (1) | CA2436916A1 (en) |
CZ (1) | CZ20031752A3 (en) |
DE (1) | DE10060388A1 (en) |
HU (1) | HUP0302645A3 (en) |
MX (1) | MXPA03004907A (en) |
PL (1) | PL361890A1 (en) |
RU (1) | RU2003119546A (en) |
SK (1) | SK8072003A3 (en) |
WO (1) | WO2002045716A1 (en) |
ZA (1) | ZA200305181B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19942474A1 (en) * | 1999-09-06 | 2001-03-15 | Merck Patent Gmbh | Pyrazolo [4,3-d] pyrimidines |
ATE478872T1 (en) * | 2002-03-28 | 2010-09-15 | Ustav Ex Botan Av Cr V V I I O | PYRAZOLOA4,3-DÜPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC USE |
KR100468352B1 (en) * | 2002-09-24 | 2005-01-27 | 한국과학기술연구원 | New pyrazolopyrimidine derivatives, process for their preparation and pharmaceutical composition comprising the same |
ATE475421T1 (en) * | 2003-05-06 | 2010-08-15 | Ustav Ex Botan Akademie Ved Ce | PYRAZOLOA4,3-DÜPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
BRPI0906475A2 (en) | 2008-01-11 | 2015-07-14 | Natco Pharma Ltd | Compounds, process for preparing a compound, pharmaceutical composition and use of a compound |
TW202019425A (en) * | 2018-07-20 | 2020-06-01 | 德商馬克專利公司 | Methods for treatment and prevention of multiple sclerosis using substituted amino-pyrimidine compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1530747A (en) * | 1976-04-05 | 1978-11-01 | Massachusetts Inst Technology | Pharmaceutical composition |
CA2238283C (en) * | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
-
2000
- 2000-12-05 DE DE10060388A patent/DE10060388A1/en not_active Withdrawn
-
2001
- 2001-11-09 RU RU2003119546/15A patent/RU2003119546A/en not_active Application Discontinuation
- 2001-11-09 KR KR10-2003-7007498A patent/KR20030055338A/en not_active Application Discontinuation
- 2001-11-09 HU HU0302645A patent/HUP0302645A3/en unknown
- 2001-11-09 WO PCT/EP2001/013036 patent/WO2002045716A1/en not_active Application Discontinuation
- 2001-11-09 CA CA002436916A patent/CA2436916A1/en not_active Abandoned
- 2001-11-09 SK SK807-2003A patent/SK8072003A3/en unknown
- 2001-11-09 CZ CZ20031752A patent/CZ20031752A3/en unknown
- 2001-11-09 BR BR0115911-9A patent/BR0115911A/en not_active Application Discontinuation
- 2001-11-09 US US10/433,678 patent/US20040023991A1/en not_active Abandoned
- 2001-11-09 MX MXPA03004907A patent/MXPA03004907A/en unknown
- 2001-11-09 JP JP2002547500A patent/JP2004523493A/en active Pending
- 2001-11-09 AU AU2002216033A patent/AU2002216033A1/en not_active Abandoned
- 2001-11-09 PL PL01361890A patent/PL361890A1/en unknown
- 2001-11-09 EP EP01999373A patent/EP1339410A1/en not_active Withdrawn
- 2001-11-09 CN CNA018200737A patent/CN1479619A/en active Pending
-
2003
- 2003-07-03 ZA ZA200305181A patent/ZA200305181B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2436916A1 (en) | 2002-06-13 |
CN1479619A (en) | 2004-03-03 |
RU2003119546A (en) | 2004-12-27 |
MXPA03004907A (en) | 2003-09-05 |
HUP0302645A3 (en) | 2005-05-30 |
SK8072003A3 (en) | 2003-10-07 |
PL361890A1 (en) | 2004-10-04 |
KR20030055338A (en) | 2003-07-02 |
HUP0302645A2 (en) | 2003-11-28 |
BR0115911A (en) | 2004-02-25 |
EP1339410A1 (en) | 2003-09-03 |
US20040023991A1 (en) | 2004-02-05 |
ZA200305181B (en) | 2004-10-04 |
CZ20031752A3 (en) | 2003-10-15 |
WO2002045716A1 (en) | 2002-06-13 |
JP2004523493A (en) | 2004-08-05 |
DE10060388A1 (en) | 2002-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI1220856T1 (en) | Pyrazolo(4,3-d)pyrimidine derivatives | |
EP1416935B8 (en) | 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives | |
IL158697A0 (en) | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives | |
IL152771A0 (en) | PYRROLO(2,3-d) PYRIMIDINE COMPOUNDS AS IMMUNOSUPPRESSIVE AGENTS | |
NO20022738D0 (en) | Pyrrolo (2,3-d) pyrimidine | |
AU2002327168A1 (en) | Pyrrolo(2,3-d)pyrimidine nucleoside analogs | |
SI1087971T1 (en) | PYRROLO 2,3-d)PYRIMIDINE COMPOUNDS | |
PL353366A1 (en) | Pyrazolo[4,3-d]pyrimidines | |
AU5491699A (en) | Process for the preparation of pyrrolo(2,3-d)pyrimidines | |
AU2001279700A1 (en) | 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect | |
PL358551A1 (en) | 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines | |
AU2002215979A1 (en) | Use of pyrazolo(4,3-D)pyrimidines | |
AU2002216033A1 (en) | Use of pyrazolo(4,3-d)pyrimidines | |
AU2001285785A1 (en) | 2-aminoalkyl-thieno[2,3-d]pyrimidines | |
AU2001233026A1 (en) | Phosphodiesterases | |
AU8578501A (en) | 2-aminoalkyl-thieno(2,3-d)pyrimidines | |
AU2002210526A1 (en) | Substituted 3.4-dihydro-pyrido[1,2-A]pyrimidines | |
IL155380A0 (en) | SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES | |
AU2001281142A1 (en) | Diazepinones as antiviral agents | |
AU2002214007A1 (en) | Substituted 3.4-dihydro-pyrimido(1,2-A)pyrimidines and 3.4-dihydropyrazino(1,2-A)pyrimidines | |
SI1210349T1 (en) | PYRAZOLO 4,3-d)PYRIMIDINES | |
AU2002325550A1 (en) | (1,2,4)triazolo(1,5-a)pyrimidine derivative | |
AU2002226519A1 (en) | Pyrrolo(2,3-d)pyrimidine and their use as purinergic receptor antagonists | |
AU2002244935A1 (en) | 8-thiazolyl(1,2,4)triazolo(1,5-c)pyrimidine derivative | |
AU2001291210A1 (en) | Process for the preparation of 2-alkoxy-6-trifluoromethyl-n-((1,2,4)triazolo(1,5-c)pyrimidin-2-yl)benzenesulfonamides |